Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.67
$0.393.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M |
| Total Depreciation and Amortization | 50.00K | 53.00K | 81.00K | 134.00K | 152.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 76.00K |
| Total Other Non-Cash Items | 1.58M | 888.00K | 1.48M | 1.00M | 1.64M |
| Change in Net Operating Assets | 6.16M | 122.00K | -1.00M | -2.55M | -2.03M |
| Cash from Operations | -15.55M | -16.60M | -16.42M | -10.94M | -13.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.64M | 17.74M | 18.12M | 8.73M | -15.37M |
| Cash from Investing | 19.64M | 17.74M | 18.12M | 8.73M | -15.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -10.90M |
| Issuance of Common Stock | 2.85M | -- | -- | -- | 35.94M |
| Repurchase of Common Stock | -- | -- | -- | -13.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.85M | -- | -- | -13.00K | 25.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.94M | 1.14M | 1.70M | -2.23M | -4.26M |